Skip to content

Goldman Sachs & Co. LLC

Recent events

Recent events tied to this brand in public sources.

Back to profile9 entries

  1. 2026

    BNY prices $1.25 billion preferred-stock offering

    BNY announced that it priced an underwritten public offering of 1,250,000 depositary shares representing interests in its Series O preferred stock, at an aggregate public offering price of $1.25 billion. The offering is expected to close on October 28, 2026.

  2. 2021

    Mirati Therapeutics announces pricing of public stock offering

    Mirati Therapeutics announced pricing for an underwritten public offering of 3,448,275 common shares at $145 per share, with gross proceeds expected to be approximately $500 million before expenses. The offering was expected to close on or about November 15, subject to customary closing conditions.

  3. 2021

    Sonendo prices IPO

    Sonendo priced its IPO, saying it would sell 7,800,000 shares of common stock at $12.00 per share for total gross proceeds of $93.6 million.

  4. 2021

    On announces initial public offering

    Swiss sportswear brand On announced the launch of an initial public offering of 31,100,000 Class A ordinary shares and applied to list the shares on the New York Stock Exchange under the symbol ONON. The offering remained subject to market conditions and regulatory effectiveness.

  5. 2021

    Biohaven prices $200 million public offering

    Biohaven announced the pricing of an underwritten public offering of 2,686,409 common shares at $76.00 per share, with gross proceeds expected to be approximately $200 million before expenses. The offering was expected to close on March 17, 2021, subject to customary conditions.

  6. 2021

    Switchback II Corporation commences IPO

    Switchback II Corporation announced that it had commenced an initial public offering of 25,000,000 units priced at $10.00 per unit.

  7. 2020

    Rexford Industrial announces pricing of common stock offering

    Rexford Industrial Realty announced pricing of an underwritten offering of 6,000,000 common shares for expected gross proceeds of approximately $284.4 million, before estimated offering expenses. Settlement was expected on December 4, subject to customary closing conditions.

  8. 2019

    Arrowhead Pharmaceuticals prices public stock offering

    Arrowhead Pharmaceuticals announced the pricing of an underwritten public offering of 4 million common shares at $58 per share. The offering was expected to close on or about December 6, 2019, subject to customary closing conditions.

  9. 2019

    Kodiak Sciences prices public stock offering

    Kodiak Sciences announced the pricing of an underwritten public offering of 6,000,000 common shares at $46 per share, with expected gross proceeds of approximately $276 million before expenses.